Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers

Clinical trial NCT05588609 · TERMINATED

Trial details

NCT number: NCT05588609
Sponsor: Partner Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC Harboring NRG1 Fusion Metastatic Castration-resistant Prostate Cancer

Start date: 2022-11-17
Primary completion: 2025-07-03
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.